Recent News

ESMO 2021: Final Results of Phase II Trial of First-Line Nivolumab in Squamous Cell Carcinoma

ESMO 2021: Extended-Dose Cemiplimab-rwlc Under Study in Squamous Cell Carcinoma

Topical Remetinostat Under Study in Basal Cell Carcinoma

Intraoperative Fluorescent Imaging Agent Under Study in Patients With Skin Cancer

Link Between Cutaneous HPV and Squamous Cell Skin Cancer?

Combination Checkpoint Antibody Treatment in Cutaneous Squamous Cell Carcinoma

Study Finds Stem Cell Markers Point to Origin and Prognosis in Merkel Cell Carcinoma

Does Lifetime Ambient UV Radiation Exposure Impact Skin Cancer Risk by Anatomic Site?

Is High Citrus Consumption Associated With Non-Melanoma Skin Cancer Risk?

Exclusive Radiotherapy: Potential Alternative to Surgery for Merkel Cell Carcinoma?

Use of Avelumab for Oligoprogression in Advanced Merkel Cell Carcinoma: Case Report

Checking Checkpoint Inhibitor Effectiveness in Immunocompromised Patients With Advanced Skin Cancer

Trends in Skin Cancers: Findings From Global Burden of Disease Study

Serial Excision: Appropriate Alternative to Mohs Micrographic Surgery for Non-Melanoma Skin Cancer?

Perioperative Use of Cemiplimab Under Study in Cutaneous Squamous Cell Carcinoma

FDA Expands Pembrolizumab Label for Locally Advanced Cutaneous Squamous Cell Carcinoma

ASCO 2021: Phase II Study of Domatinostat Plus Avelumab for Merkel Cell Carcinoma

ASCO 2021: Dutch Study of Postoperative Radiotherapy in Merkel Cell Carcinoma

ASCO 2021: Combination of HDAC Inhibitor and Pembrolizumab in Advanced Skin Cancer

ASCO 2021: Cemiplimab-rwlc and Quality of Life in Patients With Locally Advanced Skin Cancer

Are American Adults Taking Skin Cancer Seriously? Survey Findings Suggest Perhaps Not

ASCO 2021: Cetuximab After Disease Progression With Immunotherapy in Advanced Skin Cancer

ASCO 2021: Health-Related Quality of Life With Pembrolizumab for Cutaneous Squamous Cell Carcinoma

Australian Researchers Explore Immunotherapy-Related Concepts in Squamous Cell Skin Cancer

Does Citrus Juice Consumption Affect the Risk of Non-Melanoma Skin Cancer?

Decreasing Skin Cancer Incidence Through Restrictions on Indoor Tanning

Genetic Relationship between Non-Melanoma Skin Cancer and CLL

Exploring the Potential Role of Podoplanin in Cutaneous Squamous Cell Carcinoma

Antihypertensive Medications and Risk of Skin Cancer in Older Individuals

Let There Be Light: Can Blue Light Exposure With Cisplatin Treat Skin Cancer?

Topical MEK Inhibitor Under Study in Cutaneous Squamous Cell Carcinoma

High-Dose–Rate Brachytherapy for Non-Melanoma Skin Cancer

Do Local Excision Margins Influence Survival in Merkel Cell Carcinoma?

AACR 2021: Do Immune-Mediated Diseases Influence Risk of Skin Cancer?

Psoriasis and Risks of Basal and Squamous Cell Carcinomas

Long-Term Risk of Cutaneous Squamous Cell Carcinoma After Actinic Keratosis

AACR 2021: Is Pembrolizumab Effective in Treating Advanced Cutaneous Squamous Cell Carcinoma?

Can High-Frequency Ultrasound Improve Accuracy of Identifying Basal Cell Carcinoma?

Follow-up Care Strategy for Patients With Low-Risk Basal Cell Carcinoma

Australian Surveillance Program for Individuals at High Risk of Aggressive Skin Cancer

Role of Filaggrin Expression in Squamous and Basal Cell Carcinomas

Novel Vaccine Under Study in Basal Cell Carcinoma